GILD vs VSTD · P/E 18, rev $29.44B vs rev $12.8M
Gilead Sciences Inc (GILD) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the GILD and VSTD stock pages for the full models.
Not investment advice.